Pricing Log in Create free account

Accendra Health, Inc. (ACH) vs Cellyan Biotechnology Co., Ltd (HKPD)

Accendra Health, Inc. and Cellyan Biotechnology Co., Ltd are both Medical Distribution companies. Accendra Health, Inc. is the larger, with a market value of $23.0M against $3.4M — 6.9× the size. Across the 9 metrics below, Cellyan Biotechnology Co., Ltd leads on 5 and Accendra Health, Inc. on 4.

Valuation

Metric ACH HKPD Medical Distribution median
P/E n/m — —
P/S 0.01 — 0.27
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA 8.10 n/m 17.33
EV/Sales 0.87 n/m 0.86
Earnings yield (1,448.15%) — (13.85%)
Free cash flow yield (1,018.49%) 0.00% (6.11%)

Profitability

Metric ACH HKPD Medical Distribution median
Gross margin 44.83% — 5.74%
Operating margin 1.11% — 0.00%
Net margin (11.41%) — (11.41%)
Free cash flow margin (7.97%) 0.00% (0.36%)
Return on equity 72.63% 0.00% 0.00%
Return on assets (9.65%) 0.00% (1.95%)
Return on invested capital 1.58% 0.00% 0.00%

Growth

Metric ACH HKPD Medical Distribution median
Revenue growth (TTM) (3.30%) — 6.15%
EPS growth (last fiscal year) (202.54%) (2,521.89%) 5.18%
Revenue growth, 5-year CAGR (20.10%) — 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACH HKPD Medical Distribution median
Debt to equity (3.12) 0.10 (0.66)
Current ratio 0.41 3.86 0.99
Net debt to EBITDA 7.31 (0.79) (0.10)

Dividend

Metric ACH HKPD Medical Distribution median
Dividend yield — — —
Payout ratio — — —

Size

Metric ACH HKPD Medical Distribution median
Market cap 22.95m 3.35m 97.81m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack